Sanofi SA (EPA: SAN) is in focus today after teaming up with OpenAI to deploy artificial intelligence for drug development.
A Sanofi SA (EPA: SAN) está em foco hoje após se unir à OpenAI para implantar inteligência artificial no desenvolvimento de medicamentos. O que a Sanofi ganha com isso? Trabalhar com a empresa ...
, opens new tab on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects through the use of Artificial ...
We all want a crystal ball, something that will let us peer a few months into the future and know how the markets are going to shake out. Of course, that won’t happen – but it won’t stop ...
French pharmaceutical company Sanofi is partnering with Sam Altman's OpenAI and AI pharma company Formation Bio to expedite the development of new medicines, tapping artificial intelligence to ...
(Reuters) - French drugmaker Sanofi (NASDAQ:SNY) on Tuesday announced it is collaborating with artificial intelligence company OpenAI and Formation Bio to boost its drug development projects ...